Contracts › 75N91022C00013
75N91022C00013: Clinical Trials Monitoring Service
Awarded to Theradex Systems, Inc. by National Institutes of Health (NIH).
$44.1Mobligated
$151.8Mpotential value
30 April 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N91022C00013 |
|---|---|
| Awardee | Theradex Systems, Inc. |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NIH NCI |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN13 Health R&D Services; Health Care Services; Experimental Development |
| Place of performance | NJ |
| Offers received | 1 |
| Period of performance | 01 May 2022 to 30 April 2027 |
| Potential end | 30 April 2032 |
| Estimated recompete solicitation | ~Q4 2026 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record